Code blue
9 March 2021

DocGo’s roaming medics, merging with a blank-check firm for $1.1 bln, are a creative addition to the U.S. healthcare system. The jargon-laden business is, however, in its early stages and unprofitable. The SPAC boom has blurred the line between good ideas and good investments.